Patient Sample Collection and Screening Kit Hemoccult ICT 2-Day Colorectal Cancer Screening Fecal Occult Blood Test (iFOB or FIT) Stool Sample 50 Tests CLIA Waived

Por Mckesson
0
(0)
0 180
$158.34
En stock

695783

Description

2-Day Patient Screening Kit. Hemoccult ICT is a fecal immunochemical Test (FIT), which is clinically proven to detect bleeding associated with more cancers and polyps than traditional guaiac-based FOBTs. Because of its superior specificity for lower GI bleeding, Hemoccult ICT is an ideal screening tool for colorectal cancer (CRC). Test devices must be purchased separately. There are no diet or drug restrictions for patients to follow while they are using it, which helps increase patient compliance


Specification

  • Application : Patient Sample Collection and Screening Kit
  • CLIA Classification : CLIA Waived
  • Contents 1 : (50) Patient Screening Kits with Dispensing Envelope, Hemoccult ICT Collection Cards, Flushable Collection Tissues, Applicator Sticks, Mailing Pouch
  • HCPCS : G0328
  • Number of Tests : 50 Tests
  • Reading Type : Visual Read
  • Sample Type : Stool Sample
  • Test Format : Test Card Format
  • Test Name : Fecal Occult Blood Test (iFOB or FIT)
  • Test Type : Colorectal Cancer Screening
  • Time to Results : 1 Minute Results
  • UNSPSC Code : 41116129
Vendor McKesson
Rango de precios $51 - $100
Costo de envío
Ubicación de la tienda Irving, Texas (TX), United States (US)

No se encontraron opiniones!

No se han encontrado comentarios para este producto. ¡Sé el primero en comentar!

Welcome to shop.mhsurgicals.com..! In order to provide a more relevant experience for you, we use cookies to enable some website functionality. Cookies help us see which articles most interest you. This website or its third-party tools process personal data (e.g. browsing data or IP addresses) and use cookies or other identifiers, which are necessary for its functioning and required to achieve the purposes illustrated in the cookie policy.

You accept the use of cookies by closing or dismissing this notice, To learn more, please refer to the Cookie policy.